biomedicina slovenica

"RHEUMATIC DISEASES" : 201-300

  1. Roškar Robert
    Interakcije zdravil za zdravljenje revmatičnih bolezni
    [Interactions between drugs for treatment of rheumatic diseases]
    2013 ►
  2. Dobnik Mojca; Lorber Mateja; Pahor Artur
    Vpliv bioloških zdravil na kakovost življenja bolnikov z revmatološkim obolenjem
    [#The #impact of biologics on the quality of life of people affected by rheumatic diseases]
    2013 ►
  3. Holc Iztok
    Vročina, pogled internista - revmatologa
    [Fever - an aspect of an internist]
    2013 ►
  4. Kovačič Grobelšek Vesna; Dai Klara; Gradišnik Suzana
    Pomen kapilaroskopije pri diagnostiki revmatoloških bolezni
    [Nailfold capilaroscopy in rheumatic diseases]
    2013 ►
  5. Holc Iztok; Koren Krajnc Metka; Pahor Artur
    Nove klasifikacije in nomenklature revmatoloških bolezni
    [New classification criteria and new nomenclature of rheumatic diseases]
    2013 ►
  6. Meier FM; Frommer KW; Dinser R; Rozman B
    Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database
    2012 ►
  7. Sieper Joachim; Srinivasan Shankar; Zamani Omid; Praprotnik Sonja
    Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study
    2012 ►
  8. Tomšič Matija; Rotar Žiga
    The frequency of tuberculosis chemoprophylaxis prior to TNF-alpha inhibitor treatment, and the incidence tuberculosis infection using a two-step screening algorithm for latent tuberculosis infection: data from the BioRx.si registry
    2012 ►
  9. Vidmar Gaj; Marinček Črt; Burger Helena; Goljar nika; Majdič Neža
    Rehabilitation outcome and socioeconomic inequality - a preliminary study in Slovenia
    [Izid rehabilitacije in socioekonomska neenakost - uvodna raziskava v Sloveniji]
    2012 ►
  10. Chatzidionysiou K; Lie E; Nasonov E; Tomšič M
    Efficacy of different doses of rituximab for the treatment or RA: data from CERERRA colaboration
    2012 ►
  11. Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Lund-Hetland M; Trap U; Gabay C; van Riel P; Nordstroem D; Tomšič M
    Retreatment with Rituximab yields better clinical outcomes, especially when it is given at fixed interval: data from the Cererra collaboration
    2011 ►
  12. Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Lund-Hetland M; Tarp U; Gabay C; van Riel P; Nordstroem D; Tomšič M
    Seropositivity, and in particular ACPA positivity is a strong predictor of response to treatment with Rituximab: pooled data from 10 European registries
    2011 ►
  13. Seror R; Bowman SJ; Bootsma H; Theander E; Vitali C; Hansen A; Ramos-Casals M; Dorner T; Praprotnik S; Tomšič M
    Patient's complaints depend on systemic status in patient with primary Sjoegren's syndromes
    2010 ►
  14. Seror R; Ravaud P; Mariette X; Bootsma H; Theander E; Hansen A; Ramos-Casals M; Doerner T; Praprotnik S; Tomšič M
    EULAR Sjoegren's syndrome patient reported index (ESSPRI): development of a consensus patient index for primary Sjoegren's syndrome
    2010 ►
  15. De Vita S; Soldano F; Isola M; Monti G; Gabrielli A; Tzioufas A; Ferri C; Ferraccioli GF; Quartuccio L; Tomšič M
    Preliminary classification criteria for the cryoglobulinemic syndrome
    2010 ►
  16. Gabay C; Chatzidionysiou K; Nasonov E; Lukina G; Hetland ML; Tarp U; van Riel PL; Nordstrom D; Gomez-Reino J; Tomšič M
    Effectiveness of different DMARD co-therapies in Rituximab - treated rheumatoid arthritis (RA) patients - results of a one-year follow up study from Cerrera collaboration
    2010 ►
  17. Chatzidionysiou K; van Vollenhoven RF; Nasonov E; Lukina G; Hetland ML; Tarp U; Gabay C; van Riel PLCM; Nordsroem DC; Tomšič M
    Efficacy of Rituximab retreatment in clinical practice: data from the Cererra collaboration
    2010 ►
  18. van Vollenhoven RF; Chatzidionysiou K; Nasonov E; Lukina G; Hetland ML; Tarp U; Gabay C; van Riel PPLC; Nordstroem DC; Tomšič M
    Characterisation of RA patients not requiring retreatment with Rituximab within 12 months after the first course - a Cererra study
    2010 ►
  19. Praprotnik Sonja
    Vloga bioloških zdravil pri zdravljenju revmatskih obolenj
    [The role of biological agents in the treatment of rheumatic diseases]
    2012 ►
  20. Chatzidionysiou Katerina; Lie Elisabeth; Nasonov Evgeny; Lukina Galina; Hetland Merete Lund; Tarp Ulrik; van Riel Piet LCM; Nordstrom Dan C; Gomez-Reino Juan; Tomšič Matija
    Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration
    2012 ►
  21. Haraoui B; Smolen JS; Aletaha D; Tomšič Matija
    Treating rheumatoid arthritis to target: multinational recommendations assessment questionnaire
    2011 ►
  22. De Vita S; Soldano F; Isola M; Tomšič M
    Preliminary classification criteria for the cryoglobulinaemic vasculitis
    2011 ►
  23. Seror Raphaele; Ravaud Philippe; Praprotnik Sonja; Tomšič Matija
    EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome
    2011 ►
  24. Chatzidionysiou Katerina; Lie Elisabeth; Nasonov Evgeny; Tomšič Matija
    Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries
    2011 ►
  25. Tomšič Matija; Praprotnik Sonja; Louie James S; Townes John
    Septic arthritis
    2010 ►
  26. Weisman Michael H; Weinblatt Michael E; Louie James S; Van Vollenhoven Ronald F
    Target treatment of the rheumatic diseases
    2010 ►
  27. Perdan-Pirkmajer K; Thallinger GG; Snoj N; Čučnik S; Žigon P; Kveder T; Logar D; Praprotnik S; Tomšič M; Sodin-Šemrl S; Ambrožič A
    Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease
    2012 ►
  28. Toplak Nataša; Frenkel Joost; Ozen Seza; Lachmann Helen J
    An international registry on autoinflammatory diseases: the Eurofever experience
    2012 ►
  29. Lakota Katja; Frank Mojca; Buzan Olivio; Tomšič Matija; Rozman Blaž; Sodin-Šemrl Snežna
    Acute phase proteins in prototype rheumatic inflammatory diseases
    2011 ►
  30. Blaschke Christian; Shatky Hagit
    Linking literature, information, and knowledge for biologie. ISBM/ECCB 2009: workshop of the BioLINK special interest group; 2009 Jun 28-29; Stockholm
    2011 ►
  31. Kosmač Miha; Avčin Tadej; Toplak Nataša; Simonini Gabriele; Cimaz Ronaldo; Čurin-Šerbec Vladka
    Exploring the binding sites of anti-infliximab antibodies in pediatric patients with rheumatic diseases treated with infliximab
    2011 ►
  32. Klemenc-Ketiš Zalika; Smogavec Mateja; Softic Nina; Kersnik Janko
    Health-related quality of life: a population based study from Slovenia
    2011 ►
  33. Tyndall Anthony J; Rozman Blaž
    Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
    2010 ►
  34. Kosmač Miha; Avčin Tadej; Toplak Nataša; Simonini Gabriele; Cimaz Rolando; Čurin-Šerbec Vladka
    Anti-infliximab antibodies in pediatric patients with rheumatic diseases treated with infliximab
    2010 ►
  35. Tomažič Janez
    Biološka zdravila in okužbe
    [Biologicals and infections]
    2010 ►
  36. Komadina Radko; Preželj Janez; Rok-Simon Mateja; Fokter Samo K
    Ob zaključku desetletja gibal, Pismo uredniku Zdravniškega vestnika
    2010 ►
  37. Gradišnik Suzana; Holc Iztok; Pahor Artur
    Merila za uvedbo bioloških zdravil pri revmatoloških obolenjih
    [Treatment criteria for the use of biologic agents in rheumatic diseases]
    2010 ►
  38. Jones G; Sebba A; Gu J; Tomšič M
    Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
    2010 ►
  39. Seror Raphaele; Ravaud Philippe; Praprotnik Sonjaž; Tomšič Matija
    EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome
    2010 ►
  40. Bohanec-Grabar Petra; Rojko Sabina; Logar Dušan; Dolžan Vita
    Genetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathway
    2010 ►
  41. Klemenc-Ketiš Zalika; Kersnik Janko; Tratnik Erika
    The presence of anxiety and depression in the adult population of family practice patients with chronic diseases
    [Prisotnost anksioznosti in depresije v aktivni populaciji bolnikov s kroničnimi boleznimi]
    2009 ►
  42. van Vollenhoven RF; Chatzidionysiou K; Gabay C; Tomšič M
    Rheumatoid factor predicts response to rituximab in a European registry-based cohort: 6-month results from the collaborative European registries for rituximab in rheumatoid arthritis (CERERRA)
    2009 ►
  43. Plešivčnik-Novljan M; Rozman B; Rotar Z; Ambrožič A; Tomšič M
    Comparison of the different classification criteria sets for primary Sjoegren's syndrome - follow up study
    2009 ►
  44. Šipek-Dolničar A; Rotar Z; Tomšič M
    Incidence of systemic sclerosis in Slovenia
    2009 ►
  45. Perdan-Pirkmajer Katja; Praprotnik Sonja; Tomšič Matija
    Digital ulcers as the first manifestation of carpal tunnel syndrome
    2009 ►
  46. Koren Brigita; Homšak Matjaž; Brunčko Aleksander; Skerbinjek-Kavalar Maja; Tomazin Maja
    Revmatske bolezni pri otrocih
    2009 ►
  47. Gašperšič Nataša; Praprotnik Sonja
    Zakaj potrebujemo več vrst bioloških zdravil za zdravljenje vnetne revmatične bolezni?
    [Why do we need different biologic drugs for the treatment of the inflammatory rheumatic disease?]
    2009 ►
  48. Gradišnik Suzana; Holc Iztok; Pahor Artur
    Kolenski sklep in vnetne revmatološke bolezni
    2008 ►
  49. Holc Iztok; Gradišnik Suzana; Pahor Artur
    Zdravljenje vnetnih revmatskih bolezni z biološkimi zdravili - naše izkušnje
    [Biological medication used in the treatment of inflammatory rheumatic diseases]
    2009 ►
  50. Irman Š; Škarabot M; Mušević I; Kveder T; Rozman B; Božič B
    Observed crystallisation of annexin A5 on natural phospholipid supports its antithrombotic function
    2009 ►
  51. Omersel J; Jurgec I; Čučnik S; Kveder T; Rozman B; Sodin-Šemrl S; Božič B
    Oxidised immunoglobulins express autoimmune and pro-inflammatory activity
    2009 ►
  52. Jurgec I; Lunder M; Bratkovič T; Čučnik S; Kveder T; Rozman B; Božič B
    Hydrogen bonds are crucial for the anti-beta 2-glycoprotein I antibody bindings to the antigen
    2009 ►
  53. Lakota K; Ceribelli A; Cavazzana I; Franceschini F; Vencovsky J; Stamenkovič B; Czirjak L; Varju C; Poljšak KM
    Immunoblot analysis of anti-ku P70 and/or P80 antibodies in patients with different connective tissue diseases
    2009 ►
  54. Lakota K; Poljšak KM; Kveder T; Rozman B; Sodin-Šemrl S
    Detection of anti-serum amyloid autoantibodies on western blots implies a potential physiological role
    2009 ►
  55. Bohanec-Grabar P; Rozman B; Logar D; Praprotnik S; Dolžan V
    Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arhritis
    2009 ►
  56. Vesel T; Avčin T
    Novosti pri zdravljenju otroških revmatskih bolezni z biološkimi zdravili
    2009 ►
  57. Čelan Dušan
    Ankilozirajoči spondilitis
    2009 ►
  58. Avčin T; Canova M; Guilpain P; Guillevin L; Kallenberg CG; Tincani A; Tonon M; Zampieri S; Doria A
    Infections, connective tissue diseases and vasculitis
    2008 ►
  59. Čamernik M; Turha D
    Biološka zdravila v pediatrični revmatologiji - sodelovanje medicinske sestre pri aplikaciji in edukaciji staršev in otrok
    [Biological drugs in paediatric rheumatology - the nurse's role in drug administration and education of parents and children]
    2008 ►
  60. Lakota K; Mrak-Poljšak K; Omersel J; Rozman B; Kveder T; Tomšič M; Sodin-Šemrl S
    Influence of potential modulators lipoxin A4, black tea extract and resveratrol on interleukin-1beta- and serum amyloid A-induced inflammation and coagulation in human primary endothelial cells
    2008 ►
  61. Lakota K; Čučnik S; Žigon P; Kveder T; Tomšič M; Rozman B; Sodin-Šemrl S
    Levels of serum amyloid A and its autoantibodies in autoimmune diseases with and/or without thrombosis
    2008 ►
  62. Gašperšič N; Serša I; Jevtič V; Tomšič M; Praprotnik S
    Monitoring ankylosing spondylitis therapy by dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging
    2008 ►
  63. Lakota K; Mrak-Poljšak K; Rozman B; Kveder T; Tomšič M; Sodin-Šemrl S
    Modulation of serum amyloid a activation of human endothelial cells by transforming growth factor-alpha
    2007 ►
  64. Rozman B; Čučnik S; Sodin-Šemrl S; Czirjak L; Varju C; Distler O; Huscher D; Aringer M; Steiner G; Kveder T
    Prevalence and clinical associations of anti-KU antibodies in patients with systemic sclerosis: a European EUSTAR - initiated multicentre case-control study
    2008 ►
  65. Žigon P; Amengual O; Atsumi T; Kataoka H; Horita T; Yasuda S; Božič B; Kveder T; Rozman B; Koike T
    Binding properties of antiprothrombin antibodies to procoagulant cell surface
    2007 ►
  66. Čučnik S; Kveder T; Rozman B; Božič B
    Binding of high avidity anti-beta-2glycoprotein I antibodies to the antigen in fluid phase
    2007 ►
  67. Lakota K; Mrak-Poljšak K; Rozman B; Kveder T; Tomšič M; Sodin-Šemrl S
    Modulation of serum amyloid a activation of human endothelial cells by transforming growth factor-beta 1
    2007 ►
  68. Gradišnik Suzana; Holc Iztok; Dai Klara; Pahor Artur
    Stranski učinki bioloških zdravil pri vnetnih revmatičnih boleznih
    [Side effects of biological therapy used in inflammatory rheumatic diseases]
    2007 ►
  69. Walker UA; Rozman Blaž; Šipek Alenka
    Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database
    2007 ►
  70. Woolf Anthony D; Tomšič Matija; Praprotnik Sonja
    Healthcare services for those with musculoskeletal conditions: a rheumatology service. Recommendations of the European union of medical specialists section of rheumatology/European board of rheumatology 2006
    2007 ►
  71. Rozman B
    Symposium Immunopathology of autoimmune rheumatic diseases; 2006 May 4; Bled
    2006 ►
  72. Rozman Blaž; Shoenfeld Yehuda
    Introduction
    2006 ►
  73. Rozman Blaž; Kos-Golja Mojca
    Slovenska revmatologija: 50. obletnica resolucije o organizaciji borbe proti revmatizmu
    2006 ►
  74. Božič B; Rozman B; Tomšič M; Kveder T
    Acquired myopathies
    2006 ►
  75. Avčin T; Cimaz R; Cervera R; Ravelli A; Garay S; Pruunsild C; Dressler F; Nielsen S; Martini A; Rozman B; Meroni P
    Register for pediatric patients with antiphospholipid syndrome: European project extended internationally
    2006 ►
  76. Avčin T; Tse SML; Schneider R; Silverman ED
    Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood
    2005 ►
  77. Avčin Tadej; Kuhar Marijana
    Neonatal rheumatic diseases
    2004 ►
  78. Avčin Tadej; Tse Shirley ML; Schneider Rayfel; Ngan B; Silverman Earl D
    Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood
    2006 ►
  79. Avčin Tadej; Silverman Earl D; Forte Vito; Schneider Rayfel
    Nasal septal perforation: a novel clinical manifestation of systemic juvenile idiopathic arthritis/ adult onset Still's disease
    2005 ►
  80. Ruperto N; Garcia-Munitis P; Villa L; Pesce M; Aggarwal A; Fasth A; Avčin T; Bae SC; Balogh Z; Li C
    PRINTO/PRES international website for families of children with rheumatic diseases: www.pediatric-rheumatology.printo.it
    2005 ►
  81. Avčin Tadej; Tse Shirley ML; Schneider Rayfel; Ngan Bo; Silverman Earl D
    Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood
    2006 ►
  82. Kos-Golja Mojca; Brecelj Martina; Hočevar Alojzija; Huzjan Barbka; Kastelic-Klasinc Cvetka; Kraut Aleksandra; Lestan Boris; Logar Dušan; Pfeifer Marija; Plešivčnik-Novljan Martina; Praprotnik Sonja; Resman Dragica; Rotar Žiga; Rozman Blaž; Šipek-Dolničar Alenka; Tomšič Matija; Žlebič Jože
    Kako živeti z revmatizmom: bolečina, samopomoč, zdravljenje
    2005 ►
  83. Božič B; Čučnik S; Kveder T; Rozman B
    Changes in avidity and specificity of IgG during electro-oxidation. Relevance of binding of anti-beta2-GPI antibodies
    2006 ►
  84. Čučnik S; Kveder T; Rozman B; Božič B
    Binding of high avidity anti-beta2-glycoprotein I antibodies does not depend on antigen density
    2006 ►
  85. Sodin-Šemrl S; Žigon P; Čučnik S; Kveder T; Blinc A
    Serum amyloid A in autoimmune thrombosis
    2006 ►
  86. Kveder Tanja; Božič Borut
    The quality assurance and organization of autoantibody laboratory
    2005 ►
  87. Praprotnik Sonja
    Stopnje nujnosti za specialistični pregled pri revmatologu in potrebne preiskave pred napotitvijo
    2005 ►
  88. Holc Iztok; Pahor Artur
    Pomen power Doppler ultrazvoka v diagnostiki vnetnih revmatskih bolezni
    [The importance of power Doppler imaging in the diagnostics of inflammatory rheumatic diseases]
    2005 ►
  89. Hočevar A; Rainer S; Rozman B; Zor P; Tomšič M
    Ultrasonographic changes of major salivary glands in primary Sjoegren's syndrome. Evaluation of novel scoring system
    2005 ►
  90. Čučnik S; Božič B; Kveder T; Tomšič M; Rozman B
    Avidity of anti-beta2-glycoprotein I and thrombosis or unsuccessful pregnancy in patients with antiphospholipid syndrome
    2005 ►
  91. Logar D; Praprotnik S; Vidmar G; Lestan B; Rozman B; Kos-Golja M; Kastelic-Klasinc C; Tomšič M
    Evaluation of joint inflammation in patients with rheumatoid arthritis treated with etanercept (Enbrel) by simple measurement of joint effusion area and synovial area by means of high-resolution ultrasonography
    2005 ►
  92. Asherson RA; Espinosa G; Cervera R; Gomez-Puerta JA; Musuruana J; Bucciarelli S; Ramos-Casals M; Martinez-Gonzalez AL; Praprotnik S; Šipek-Dolničar A
    Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients
    2005 ►
  93. Žigon P; Božič B; Čučnik S; Rozman B; Tomšič M; Kveder T
    Are autoantibodies against a 25-mer synthetic peptide of M3 muscarinic acetylcholine receptor a new diagnostic marker for Sjoegren's syndrome?
    2005 ►
  94. Gradišnik Suzana; Pahor Artur; Holc Iztok
    Osteoporoza in revmatske bolezni
    [Osteoporosis and rheumatic diseases]
    2005 ►
  95. Tomšič Matija; Kveder Tanja; Božič Borut; Lestan Boris; Logar Dušan; Rainer Saša; Jevtić Vladimir; Praprotnik Sonja; Hočevar Alojzija; Plešivčnik-Novljan Martina; Kos-Golja Mojca; Strle Franc; Ambrožič Aleš; Rozman Blaž; Šipek-Dolničar Alenka; Gašperšič Nataša
    Revmatične bolezni
    2005 ►
  96. Bird HA; Leeb BF; Montecucco CM; Misiuniene N; Nesher G; Pai S; Pease C; Rovensky J; Rozman B
    A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica
    2005 ►
  97. Praprotnik S; Rozman B; Tomšič M
    New issues in tuberculosis
    2005 ►
  98. Kos-Golja Mojca
    Smotrno zdravljenje revmatske bolečine
    2004 ►
  99. Mitrović Nina; Trontelj Benjamin; Lebar Cecilija
    Delovnoterapevtske storitve na področju revmatologije in medicinske rehabilitacije
    2004 ►
  100. Pahor A; Hojs R; Rozman B; Holc I; Gradišnik S
    Asymptomatic atherosclerosis in normotensive non-diabetic patients with rheumatoid arthritis
    2004 ►

   1 101 201 301 401  


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics